About Szegedi Tudományegyetem ÁOK; Department of Ophtalmology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Aerie Pharmaceuticals
1
Recordati Rare Diseases
1
Clinical Trials at Szegedi Tudományegyetem ÁOK; Department of Ophtalmology
During the past decade, Szegedi Tudományegyetem ÁOK; Department of Ophtalmology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on
average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
2017-09-05
2020-11-06
Completed
436
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
2018-09-05
2021-09-03
Completed
940
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
2019-03-11
2022-01-07
Completed
658
REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients
2020-10-13
2024-05-01
Recruiting
108
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
2020-08-05
2023-08-18
Active, not recruiting
1,479
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
2021-03-02
2023-06-15
Active, not recruiting
553
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
2021-03-02
2023-07-13
Active, not recruiting
729
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
2021-04-19
2024-08-09
Active, not recruiting
1,036
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Szegedi Tudományegyetem ÁOK; Department of Ophtalmology"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Szegedi Tudományegyetem ÁOK; Department of Ophtalmology
According to Clinical.Site data, the most researched conditions in "Szegedi Tudományegyetem ÁOK; Department of Ophtalmology" are
"Diabetic Macular Edema" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials) and "Hemiretinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Szegedi Tudományegyetem ÁOK; Department of Ophtalmology" in a lesser frequency.
Clinical Trials Intervention Types at Szegedi Tudományegyetem ÁOK; Department of Ophtalmology
Most popular intervention types in "Szegedi Tudományegyetem ÁOK; Department of Ophtalmology" are "Drug" (8 trials), "Procedure" (4 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "GANFORT®" (1 trials) and "Netarsudil/Latanoprost 0.02%/0.005%" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Szegedi Tudományegyetem ÁOK; Department of Ophtalmology
The vast majority of trials in "Szegedi Tudományegyetem ÁOK; Department of Ophtalmology" are
8 trials for "All" genders.
Clinical Trials Status at Szegedi Tudományegyetem ÁOK; Department of Ophtalmology
Currently, there are NaN active trials in "Szegedi Tudományegyetem ÁOK; Department of Ophtalmology".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Szegedi Tudományegyetem ÁOK; Department of Ophtalmology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Szegedi Tudományegyetem ÁOK; Department of Ophtalmology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".